Adam S Faye

29PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityImmunogenetics (incl. genetic immunology)PharmacogenomicsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Oct 07, 2026
Early Colectomy and Long-Term Risk of Cardiometabolic Disease in Ulcerative Colitis: A Nationwide Cohort Study.

|Apr 15, 2026
Corticosteroid Initiation Before Antimicrobials Does Not Increase the Risk of Adverse Outcomes Among Individuals Hospitalized With an IBD Flare and Enteric Infection.

|Feb 13, 2026
The Bidirectional Relationship Between Cognitive Function and Active Inflammatory Bowel Disease.

Bharati Kochar, Adam S Faye, Elizabeth Araka

|Feb 10, 2026
Proton Pump Inhibitors Are More Cost-Effective Than Potassium Competitive Acid Blockers for Gastroesophageal Reflux Disease.

Kate L Karlin, Ella H Gilbert, Francesca Lim

|Nov 22, 2025
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age.

Adam S Faye, David T Rubin, Corey A Siegel

|Nov 07, 2025
Clostridioides difficile Infection Is Associated With Increased Colectomy Risk in Acute Severe Ulcerative Colitis Treated With Infliximab.

Tamara F Kahan, Olivia Delau, Simon Hong

Pageof 5

Frequent Collaborators

6 joint publications

Jordan E Axelrad

3 joint publications

Kate L Karlin

3 joint publications

Bharati Kochar

2 joint publications

Jonas Halfvarson